CA 19-9 monosialoganglioside content of human colorectal tumor cells correlates with tumor cell-induced platelet aggregation

Anticancer Research

Volumn 20, Issue 3 A, 2000, Pages 1609-1614

  Martini, Francesca ^a   Guadagni, Fiorella ^b   Lenti, Luisa ^a   D'Alessandro, Roberta ^b   Aloe, Simona ^b   Roselli, Mario ^c   Gazzaniga, Pier Paolo ^a   Ferroni, Patrizia ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

CA 19 9; Colorectal cancer; Gangliosides; Haematogenous metastases

Indexed keywords

CA 19-9 ANTIGEN; GANGLIOSIDE; MONOSIALOGANGLIOSIDE; SIALIC ACID;

ARTICLE; CELL INTERACTION; COLORECTAL TUMOR; CONTROLLED STUDY; HUMAN; HUMAN CELL; METASTASIS; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION;

CA-19-9 ANTIGEN; COLORECTAL NEOPLASMS; GANGLIOSIDES; HUMANS; PLATELET AGGREGATION; TUMOR CELLS, CULTURED;

EID: 0033854185     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Magnani JL, Brockhaus M, Smith DF et al: A monosialo-ganglioside is a monoclonal antibody-defined antigen of colon carcinoma. Science 212: 55-56, 1981.
2. Magnani JL, Nilsson B, Brockhaus M et al: A monoclonal antibody-defined antigen associated with gastrointestinal cancer is a ganglioside containing sialylated lacto-N-fucopentaose II. J Biol Chem 257: 14365-14369, 1982.
3. a antigen. J Biol Chem 260: 9388-9392, 1985.
4. Magnani JL, Steplewzski Z, Koprowski H and Ginsburg V: Identification of the gastrointestinal and pancreatic cancer-associated antigen detected by monoclonal antibody 19.9 in the sera of patients as a mucin. Cancer Res 43: 5489-5492, 1983.
5. Herlyn M, Sears HF, Steplewski Z and Koprowski H: Monoclonal antibody detection of a circulating tumor-associated antigen. I. Presence of antigen in sera of patients with colorectal, gastric and pancreatic carcinoma. J Clin Immunol 2: 135-140, 1982.
6. Ritts RE Jr, Del Villano BC, Go VL, Herberman RB, Klug TL and Zurawski VR Jr: Initial clinical evaluation of an immunoradiometric assay for CA 19-9 using the NCI serum bank, Int J Cancer 33: 339-345, 1984.
7. Guadagni F, Roselli M, Amato T, et al: CA 72-4 measurement of tumor-associated glycoprotein 72 (TAG-72) as a serum marker in the management of gastric carcinoma. Cancer Res 52: 1222-1227, 1992.
8. a as a new prognostic factor for patients with advanced colorectal carcinoma. Cancer 75: 2051-2056, 1995.
9. Isozaki H, Ohyama T and Mabuchi H: Expression of cell adhesion molecule CD44 and sialyl Lewis A in gastric carcinoma and colorectal carcinoma in association with hepatic metastasis. Int J Oncol 13: 935-942, 1998.
10. Morales-Gutierrez C, Vegh I Colina F, et al: Survival of patients with colorectal carcinoma: possible prognostic value of tissular carbohydrate antigen 19.9 determination. Cancer 86: 1675-1681, 1999.
11. Varki A: Selectin ligands. Proc Natl Acad Sci USA 91: 7390-7397, 1994.
12. Dejana E, Bertocchi M, Bortolami A, Regonesi A, Tonta F and Giavazzi R: Interleukin-1 promotes tumor cell adhesion to cultured human endothelial cells. J Clin Invest 82: 1466-1470, 1988.
13. Rice G and Bevilacqua M: An inducible endothelial cell surface glycoprotein mediates melanoma adhesion. Science 246: 1303-1470, 1988.
14. Honn KV, Tang DG and Chen YQ: Platelets and cancer metastasis: more than an epiphenomenon. Semin Thromb Haemostas 18: 390-413, 1992.
15. Stone JP and Wagner DD: P-selectin mediates adhesion of platelets to neuroblastoma and small cell lung cancer. J Clin Invest 92: 804-813, 1993.
16. Mannori G, Crottet P, Cecconi O et al: Differential colon cancer cell adhesion to E-, P-, and L-selectin: role of mucin type glycoproteins. Cancer Res 55: 4425-4431, 1995.
17. Kim YJ, Borsig L, Varki NM and Varki A: P-selectin deficiency attenuates tumor growth and metastasis. Proc Natl Acad Sci USA 95: 9325-9330, 1998.
18. Ferroni P, Guadagni F, Pavan A, Martinico E, Torrisi MR and Gazzaniga PP: Platelet proaggregating activity of human colorectal tumor cell lines does not correlate with the degree of differentiation. Eur J Cancer 29: 1028-1033, 1993.
19. Ferroni P, Lenti L Guadagni F et al: Possible involvement of tumour cell membrane gangliosides in platelet-tumour cell interactions. Eur J Cancer 31: 79-84, 1995.
20. Jourdian GW, Dean L, Roseman S: A periodate-resorcinol method for the quantitative estimation of free sialic acid and their glycosides. J Biol Chem 246: 430-435, 1971.
21. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-271, 1951.
22. Ladisch S and Gillard B: A solvent partition method for microscale ganglioside purification. Analytical Biochem 146: 220-222, 1985.
23. x carbohydrate antigen in benign and malignant gastrointestinal mucosa. Cancer 73: 1552-1561, 1994.
24. Holmes EH, Hakomori S and Ostrander GK: Synthesis of type 1 and 2 lacto series glycolipid antigens in human colonic adenocarcinoma and derived cell lines is due to activation of a normally unexpressed β1-3N-acetylglucosaminyltransferase. J Biol Chem 262: 15649-15658, 1987.
25. Holmes EH and Greene T: Alteration of lacto-series glycolipid glycosyltransferase activities in human colonic adenocarcinoma DLD-1 cells afterculture in N,N-dimethylformamide-containing medium. J Cell Biochem 44: 93-105, 1990.
26. Sato M, Narita T, Kimura N et al: The association of sialyl Lewis(a) antigen with the metastatic potential of human colon cancer cells. Anticancer Res 17: 3505-3511, 1997.
27. Klopocki AG, Laskowska A, Antoniewicz-Papis J, Duk M, Lisowska E and Ugorski M: Role of sialosyl Lewis(a) in adhesion of colon cancer cells - the antisense RNA approach. Eur J Biochem 253: 309-318, 1998.
28. Hakomori S: Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. Cancer Res 56: 5308-5318, 1996.